Stock listing
Immunome, Inc.
Selected listing: IMNM · NASDAQ · USD · US
Immunome, Inc. (NASDAQ:IMNM), Health Technology. Latest release Oct 6, 2026: Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- Ticker
- NASDAQ:IMNM
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Immunome, Inc.
Immunome, Inc. is a public company traded under the ticker IMNM in the American market. The company's commitment to advancing healthcare is reflected in its research and development efforts.
Latest news from Immunome, Inc.
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 6, 2026
Immunome Announces IND Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors
September 30, 2026
Immunome to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 2, 2026
Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-3050, an FAP-Targeted Radioligand Therapy, in Patients with FAP-Expressing Advanced Solid Tumors
July 20, 2026